Vantage logo

Big pharma freshens up

Reliance on established drugs lessened for most large drug makers last year, but staleness is creeping in at Merck and Bristol.

Vantage logo

Go or no go? The FDA plays hardball

April will see the US regulator examine Pfizer’s Jak in atopic dermatitis, and experts meet to discuss accelerated approvals in oncology.